Eton Pharmaceuticals Inc (ETON)

NASDAQ
3.030
+0.010(+0.33%)
  • Volume:
    24,224
  • Day's Range:
    2.990 - 3.060
  • 52 wk Range:
    1.950 - 4.780

ETON Overview

Prev. Close
3.02
Day's Range
2.99-3.06
Revenue
13.54M
Open
3
52 wk Range
1.95-4.78
EPS
-0.354
Volume
24,224
Market Cap
76.65M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
62,019
P/E Ratio
-8.47
Beta
1.4
1-Year Change
-17.21%
Shares Outstanding
25,297,037
Next Earnings Date
Mar 15, 2023
What is your sentiment on Eton Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Eton Pharmaceuticals Inc News

Eton Pharmaceuticals Inc Analysis

Eton Pharmaceuticals Inc Company Profile

Eton Pharmaceuticals Inc Company Profile

Employees
17

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Read More

Analyst Price Target

Average10.000 (+230.03% Upside)
High10
Low10
Price3.03
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • big trap they keep the price till to dilute the shares and after the price will go to @ 2.50 and you will loose your half capital . Sell before to be late.!
    0
    • Buy the rumours, sell the news ;)
      0
      • @ Tony big buyers buys now when somebody sells somebody buys am i right ? 50% sells- 50% buys , the big surprise is coming , 12 $ and up next week.!
        0
    • finally approved.!
      0
      • News ?
        0
        • Hi ! news FDA ? Please
          0
          • not yet if you hear something please let us know .
            0
        • https://www.globenewswire.com/news-release/2020/09/29/2101010/0/en/Eton-Pharmaceuticals-Announces-FDA-Approval-of-Orphan-Drug-ALKINDI-SPRINKLE-hydrocortisone-as-Replacement-Therapy-in-Pediatric-Patients-with-Adrenocortical-Insufficiency.html
          1
          • now is going up to 12$!they have the FDA APPROVAL:)!
            1
            • Wt?? Thqts not true
              0
            • on Nov 6 will fly what do you think Mr. Tudor ?
              0
          • is a trap:))
            0
            • eney news about FDA approval!??
              0
              • https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process
                0
            • wow!is gonna fly up!
              1